RT Book, Section
A1 Parikh, Rita
A2 Atchabahian, Arthur
A2 Gupta, Ruchir
SR Print(0)
ID 57261315
T1 Chapter 68. Heparin-Induced Thrombocytopenia
T2 The Anesthesia Guide
YR 2013
FD 2013
PB The McGraw-Hill Companies
PP New York, NY
SN 978-0-07-176049-2
LK accessanesthesiology.mhmedical.com/content.aspx?aid=57261315
RD 2024/04/19
AB Type  1:  Isolated  HIT  develops  early  in  heparin  therapy  and  is  benign.  No  resultant  bleeding  or  thrombotic  complications.  Not  mediated  by  the  immune  system:  passive  heparin  binding  to  platelets  resulting  in  a  modest  shortening  of  the  platelet  life  span.  The  platelet  count  rarely  falls  below  100  ×  109/LType  2:  Heparin-induced  thrombocytopenia  and  thrombosis  syndrome  (HITTS)  is  associated  with  severe  thrombocytopenia  and  paradoxically  thrombotic  episodes  instead  of  hemorrhagic  complications.  Occurs  in  patients  receiving  heparin  for  more  than  5  days;  may  occur  within  1  day  if  prior  heparin  therapy  exposure  <100  days